FRALIFTO Trademark

Trademark Overview

On Thursday, May 6, 2010, a trademark application was filed for FRALIFTO with the United States Patent and Trademark Office. The USPTO has given the FRALIFTO trademark a serial number of 85031940. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 31, 2020. This trademark is owned by Glaxo Group Limited. The FRALIFTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
fralifto

General Information

Serial Number85031940
Word MarkFRALIFTO
Filing DateThursday, May 6, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 31, 2020
Registration Number4453083
Registration DateTuesday, December 24, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 31, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, July 31, 2020CANCELLED SEC. 8 (6-YR)
Monday, December 24, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 24, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, November 19, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 18, 2013NOTICE OF ALLOWANCE CANCELLED
Monday, November 18, 2013TEAS DELETE 1(B) BASIS RECEIVED
Thursday, June 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2013EXTENSION 5 GRANTED
Tuesday, June 11, 2013EXTENSION 5 FILED
Tuesday, June 11, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 24, 2012EXTENSION 4 GRANTED
Monday, October 22, 2012EXTENSION 4 FILED
Monday, October 22, 2012TEAS EXTENSION RECEIVED
Tuesday, April 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 9, 2012EXTENSION 3 GRANTED
Wednesday, April 4, 2012EXTENSION 3 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Wednesday, December 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2011EXTENSION 2 GRANTED
Monday, November 28, 2011EXTENSION 2 FILED
Monday, November 28, 2011TEAS EXTENSION RECEIVED
Tuesday, November 22, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2011EXTENSION 1 GRANTED
Wednesday, June 8, 2011EXTENSION 1 FILED
Tuesday, June 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 8, 2011TEAS EXTENSION RECEIVED
Tuesday, December 14, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2010PUBLISHED FOR OPPOSITION
Saturday, September 11, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 10, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 8, 2010ASSIGNED TO LIE
Friday, August 20, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION WRITTEN
Wednesday, July 14, 2010ASSIGNED TO EXAMINER
Wednesday, May 12, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 10, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

fralifto pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic